News

  • Accelerators fail women entrepreneurs in gender-unequal countries, study finds

    In countries where the gender playing field still steeply tilts toward male advantage, women-led businesses that participated in accelerators showed no financial improvement, or even did worse, compared to ventures that applied but weren't accepted, a study revealed. The researchers drew on data for more than 1,400 ventures across 65 countries that had applied to [...]

  • Two weeks left to make your mark in women’s cardiovascular health

    Cardiovascular disease is the leading cause of death in women worldwide yet the gap between what we know and what reaches female patients remains stubbornly wide. If your work is helping to close that gap, the Cardiovascular Health Innovation Award sponsored by Women As One was made for you. Entry closes in just over two [...]

  • Genital menopause symptoms: What to expect and when to see a doctor

    Article produced in association with Spital Clinic Genitourinary syndrome of menopause (GSM) affects around one in two women after the menopause — and fewer than one in three of those affected ever bring it up with a doctor. The condition covers a cluster of vaginal, urinary, and sexual symptoms caused by falling oestrogen levels during [...]

  • Three sessions that show exactly where women’s health is heading in 2026

    The women's health sector is no longer just building a case for itself.  Capital is moving, consolidation is accelerating, and the companies that understood the opportunity early are now focused on one thing: scale.  The conversations happening at Women's Health Week USA on May 13-14 at the New York Academy of Medicine reflect exactly that [...]

  • Just over two weeks left to submit your menstrual health innovation

    The Femtech World Menstrual Health Innovation Award entry window closes two weeks tomorrow (April 17). Despite affecting roughly half the global population for a significant portion of their lives, menstrual healthcare has historically been underfunded, under-researched and underrepresented on the main stages of health technology. This award, sponsored by Premom, exists to shine a light [...]

  • Female-led startups expanding despite lack of structured support, research finds

    Female-led startups are growing despite a support gap and limited structured help, according to new research. Research from Small Business Britain, in partnership with Starling Bank, found that more than eight in 10 women, or 82 per cent, aim to grow their business in the next 12 months. More than half, 53 per cent, said [...]

  • How NIPT has evolved and what AI NIPT means in 2026

    Article produced in association with London Pregnancy Clinic and Spital Clinic Non-invasive prenatal testing has been part of antenatal care in the UK since the early 2010s. In the years since its introduction, the test has undergone significant expansion in terms of what it can detect, how early it can be performed, and how its [...]

  • Time is running out to nominate your women’s cancer innovators

    The Femtech World Awards are celebrating the innovators revolutionising the way we diagnose and treat cancer in women. Cancer is a major public health and economic issue. Female breast cancer is the most commonly diagnosed cancer in the world, with an estimated 2.3 million cases diagnosed globally in 2020 alone. However, what once seemed impossible [...]

  • Menopause reshapes breast tissue, possibly raising cancer risk – study

    More than three million cells have been mapped, showing how breast tissue changes with age, with the biggest shifts seen during menopause. The research, described as the most detailed map of its kind so far, shows that as women age, all types of cells in breast tissue become fewer, those cells divide less often, and [...]

  • Copper coil vs Mirena: Which is right for you?

    Article produced in association with Spital Clinic Both the copper coil and the Mirena are more than 99 per cent effective as contraceptives — but they work in completely different ways, have opposite effects on periods, and suit very different people.   With the FSRH's May 2024 licence extension for the Mirena now [...]